Sir, Ocular m y asthenia presenting in an ll-month-old boy Ocular myasthenia is uncommon in childhood. A case of an ll-month-old boy with ocular myasthenia confirmed by a positive Tensilon test and positive serology for ac etylcholine receptor antibodies (AChR-ab) is described.
his eyes immediately on waking but had increasing difficulty in doing so after several hours. This pattern was repeated after periods of sleep.
He was born by normal vaginal delivery at term and was otherwise fit and well. He had normal motor development and had no difficulty in feeding, swallowing or breathing. His parents were fit and well, as were his two sisters and a brother aged 7 years, 2 years and 6 weeks respectively. The parents were unaware of any first-degree relatives with similar symptoms, al though it was difficult to be certain as most of their relatives lived abroad.
On examination, he was noted to have bilateral ptosis with poor orbicularis tone (Fig. 1) . He also had limitation of adduction and elevation of both eyes. Both pupils were equal and reactive and fundoscopy was normal.
Myasthenia gravis was suspected clinically and a
Tensilon test was performed in theatre with an anaesthetist present; 1 mg of edrophonium (100 flog/kg) was administered intravenously. This was strongly positive (Fig. 2) . Although at present it appears that this case may be unique, long-term follow-up is obviously essential to exclude the development of generalised myasthenia in the future.
Sir,
Asymptomatic vaso-occlusive retinopathy in Hughes' syndrome The antiphospholipid (APL) syndrome, first described in 1983/ is a disorder associated with specific antibodies directed against phospholipids, particularly cardiolipin and phosphatidyl serine. Present also are elevated levels of the lupus anticoagulant. Although originally studied in patients with systemic lupus erythematosus (secondary APL), APL is now known to occur as a primary (Hughes') syndrome? The main clinical feature is thrombosis, both venous and arterial, and the major feature of the syndrome in women is recurrent miscarriages? The eye may be involved symptomatically as a feature of transient ischaemia,4,5 or as a direct, local, ischaemic event.6-9 We report here a patient who presented with severe vaso-occlusive retinal disease in the absence of any ocular symptoms.
Case report
A 48-year-old white man was referred to us by his optician who noted several 'haemorrhages' in both retinae with new vessels at the left optic disc. He had no ocular symptoms other than presbyopia. Eleven months earlier, he had been investigated by the physicians for fatigue, sleeplessness and weight loss, associated with hypertension.
The ESR was 30 mm in the first hour (Westergren). Fasting blood sugar was normal. The platelet count was 79 X 109/1 (normal 120-400 X 109/1). Prothrombin time, fibrinogen and fibrinogen degradation products were normal but the augmented partial thromboplastin test (APTT) was raised at 47 s (normal 29-37 s). The Dilute Russell Viper Venom Time Ratio was 1.50 (normal 0.8-1.12). The following tests were normal/negative: autoantibodies to glomerular basement membrane, anti double-stranded DNA, complement C3 and C4, c-ANCA and p-ANCA, serum electrophoresis, and Bence-Jones protein, He had a positive antinuclear antibody and raised titre of anticardiolipin antibody (IgG, 23 GPL u/ ml; and IgM, 3 MPL/ml). With a diagnosis of accelerated hypertension secondary to the antiphospholipid syndrome, antihypertensive medication was started.
At presentation to the eye clinic, the patient was well and his blood pressure was 155/85 mmHg. Visual acuity was 6/6 and N5 either eye. There was no afferent pupillary defect. Anterior segments were normal, and intraocular pressures were 14 mmHg in both eyes, Fundus examination showed occluded and sheathed arterioles in the mid-periphery of both eyes, together with frank neovascularisation at the left optic disc (Fig. 1) . Fluorescein angiography showed peripheral arteriolar attenuation with frank occlusion at some points (Fig. 2) . We performed left panretinal argon laser photocoagulation. Simultaneously, the patient was referred to the haematologist who commenced him on warfarin 5 mg o.d. to prevent further vaso-occlusion, 
